Fuxing China Group Limited (SGX:AWK)

Ligand Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY	FY 2023	FY	FY 2022
Period Ending	Dec 31, 2024	Mar 31, 2024	Dec 31, 2023	Mar 31, 2023	Dec 31, 2022
Cash & Equivalents	132.95	-	80.28	-	125.58
Cash & Short-Term Investments	132.95	-	80.28	-	125.58
Cash Growth	-	-	-	-	4.76%
Accounts Receivable	244.96	-	210.32	-	260.78
Other Receivables	20.55	-	31.68	-	25.75
Receivables	265.51	-	242	-	286.53
Inventory	66.44	-	80.32	-	52.39
Prepaid Expenses	3.9	-	4.73	-	3.79
Other Current Assets	90.22	-	118.15	-	98.86
Total Current Assets	559.01	-	525.47	-	567.14
Property, Plant & Equipment	270	-	300.96	-	336.22
Other Intangible Assets	24.91	-	23.31	-	24.22
Other Long-Term Assets	42.06	-	42.06	-	38.6
Total Assets	895.98	-	891.81	-	966.18
Accounts Payable	15.51	-	11.6	-	22.91
Accrued Expenses	39.24	-	43.91	-	57.53
Short-Term Debt	213.36	-	212	-	252.65
Current Income Taxes Payable	3.83	-	3.6	-	4.33
Current Unearned Revenue	32.48	-	27.1	-	23.74
Total Current Liabilities	304.42	-	298.21	-	361.15
Long-Term Deferred Tax Liabilities	19.87	-	19.87	-	18.82
Total Liabilities	324.29	-	318.08	-	379.98
Common Stock	1.87	-	772.57	-	772.57
Additional Paid-In Capital	638.52	-	39.57	-	39.57
Retained Earnings	67.83	-	-104.62	-	-93.59
Treasury Stock	-6.41	-	-6.41	-	-6.41
Comprehensive Income & Other	-130.63	-	-127.84	-	-126.31
Total Common Equity	571.18	-	573.28	-	585.84
Minority Interest	0.51	-	0.44	-	0.36
Shareholders' Equity	571.69	-	573.72	-	586.2
Total Liabilities & Equity	895.98	-	891.81	-	966.18
Total Debt	213.36	-	212	-	252.65
Net Cash (Debt)	-80.41	-	-131.72	-	-127.07
Net Cash Per Share	-4.67	-	-7.66	-	-7.39
Filing Date Shares Outstanding	17.21	-	17.21	-	17.21
Total Common Shares Outstanding	17.21	-	17.21	-	17.21
Working Capital	254.59	-	227.26	-	205.99
Book Value Per Share	33.20	-	33.32	-	34.05
Tangible Book Value	546.27	-	549.97	-	561.62
Tangible Book Value Per Share	31.75	-	31.96	-	32.64
Buildings	338.57	-	337.51	-	337.51
Machinery	289.51	-	290.16	-	284.45
Construction In Progress	2.12	-	-	-	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.